First copies of Gilead’s Covid-19 drug to start selling in Bangladesh Bangladesh’s Beximco Pharmaceuticals Ltd. said it has become the world’s first company to start selling the generic version of Gilead Sciences Inc.’s antiviral drug on mounting urgency to treat the infection caused by the deadly coronavirus across the developing world. The Dhaka-based Beximco, which…